By 2020, about 4 million people were on GLP-1s, but by 2026, that number has soared to an estimated 30 million
The panel will review the evidence supporting the use of these peptides for specific indications, including ulcerative colitis, wound healing, obesity and migraines
By this point, the peptide has established consistent signaling, and cumulative fat mobilization produces visible changes
In most cases, these side effects should be temporary
#17 Worked my way up from 2mg to 4 for a few months and now Ive been on 6 for the last few weeks, nothing noticable for me #18 I have no raised RHR at all on Reta, currently at 2mg every 5 days, which I will be bumping up to 3mg/week, since 2mg every 5 days equals to 2.8mg/week #20 Worked my way up from 2mg to 4 for a few months and now Ive been on 6 for the last few weeks, nothing noticable for me See below
Then, tendons